Atropos Health Announces Data Quality ScoreCard and AI Tools as New Benefits to All Atropos Evidence Network Members
2024年9月20日 - 10:00PM
ビジネスワイヤ(英語)
Atropos Health today announced the availability of Data Quality
ScoreCards to members of the Atropos Evidence™ Network, the largest
federated healthcare data network with 300M+ patient records. By
joining the Atropos Evidence Network, data contributors receive
confidential, transparent, analytically driven feedback on their
own data quality and strengths and access to the most advanced AI
tools.
The rise of networks linking many real-world data (RWD) sources
from multiple providers is creating new paradigms for healthcare
research and drug safety surveillance. The previously introduced
Real World Data Score™ (RWDS) and Real World Fitness Score™ (RWFS)
present the advantage of transparency as the metrics and weights
used to calculate each score can be available along with the final
scores themselves. This capability comes native with the
installation of Atropos Health’s GENEVA OS™, a cloud-based
federated technology that can be installed atop existing healthcare
data lakes. This is an important industry movement, as noted in a
recent release by https://leavittpartners.com/data-quality/ that
highlights the levels of data quality standards in healthcare.
Atropos Health is well aligned to this guidance developed by public
and private sector leaders that included CMS, NCQA, VA, and other
industry stakeholders.
The Data Quality ScoreCard enables data holders across the
growing Atropos Evidence™ Network to confidentially measure,
evaluate, compare, and benchmark their data quality based on
objective criteria. With this scoring system, data holders know
where they rank in relation to evidence network averages. Atropos
Health benchmarks datasets using existing studies from Alexandria™,
the Atropos Evidence™ Library. Included in the Data Quality
ScoreCard is a narrative which includes tips and suggestions for
improving data quality. For one data owner, their score in May was
67; by taking suggestions by Atropos Health included in the Data
Quality ScoreCard their score climbed to 75 in July and 85 in
August.
“With a growing number of members in the Atropos Evidence
Network, the Data Quality ScoreCard provides them with a valuable
and tangible asset with which to objectively measure the value of
the investments they have made in data quality and data enrichment
and highlight their value to a variety of use cases,” said Dr.
Brigham Hyde, CEO and co-Founder of Atropos Health. “In addition to
the Data Quality ScoreCard, members also receive the benefit of
Atropos Health advanced tools to run queries and create their own
studies.”
Atropos Evidence Network members also enjoy other benefits
including evidence generation tools ChatRWD™, Green Button™, Forge™
(fka Workbench), as well as Alexandria (a library of studies),
clinical trial runs and vector databases. Benefits are based on
membership packages. Potential members can select from Silver,
Gold, and Platinum packages that are designed to meet a range of
needs. For example, members who need access to data and have a
limited number of questions are more likely to choose the Silver
package, while those with robust data needs and RWE power users are
a better fit for the Platinum package.
Atropos Health recently announced the addition of Forian,
Syndesis Health, and Norstella into the Atropos Evidence Network.
The Atropos Evidence Network is built for the purpose of
democratizing data for life science and healthcare organizations
who are seeking evidence for decision-making in medicine. The
Atropos Evidence Network already includes an impressive slate of
leaders in the healthcare data ecosystem, including Arcadia.
“With the Data Quality ScoreCard, we could easily identify the
strengths and weaknesses of our existing data,” said Michael
Meucci, CEO of Arcadia. “We clearly understand how to invest to
improve it further, and how to highlight our strengths versus
benchmarks for the key use cases we serve, unlocking greater
ability for our customers to use the data to deliver on our mission
– to improve healthcare outcomes.”
When it comes to data science and AI applications for clinical
Q&A, Atropos Health answers clinical questions fast,
transparently, and with previously unavailable information and
data, enabling studies to be run on multiple datasets at once.
About Atropos Health
Atropos Health is the developer of GENEVA OS™, the operating
system for rapid healthcare evidence across a robust network of
real-world data. Healthcare and life science organizations work
with Atropos Health to close evidence gaps from bench to bedside,
improving individual patient outcomes with data-driven care,
expediting research that advances the field of medicine, and more.
We aim to transform healthcare with timely, relevant real-world
evidence.
To learn more about Atropos Health, visit www.atroposhealth.com
or connect through LinkedIn or follow on X (Twitter)
@AtroposHealth.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240920526096/en/
Bruno Solari atropos@solcomms.co